Vincenzo Trischitta

Pubblicazioni

Titolo Pubblicato in Anno
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Leveraging Genetics to Address the Role of GALNT2 on Atherogenic Dyslipidemia ADVANCED BIOLOGY 2023
Monogenic diabetes NATURE REVIEWS. DISEASE PRIMERS 2023
Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes GENES 2022
Role of GALNT2 on Insulin Sensitivity, Lipid Metabolism and Fat Homeostasis INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2022
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes ACTA DIABETOLOGICA 2022
The Need to Increase Clinical Skills and Change the Genetic Testing Strategy for Monogenic Diabetes DIABETES 2022
Circulating Metabolites Associate With and Improve the Prediction of All-Cause Mortality in Type 2 Diabetes. DIABETES 2022
On the emerging role of GALNT2 on intermediate metabolism and adipogenesis ACTA DIABETOLOGICA 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes DIABETES & METABOLISM 2022
Contribution of ONECUT1 variants to different forms of non-autoimmune diabetes mellitus in Italian patients ACTA DIABETOLOGICA 2022
{MODY} patients carrying mutation in syndromic diabetes genes. An Italian single-center experience ACTA DIABETOLOGICA 2022
Morphological and molecular characterization of GALNT2-mediated adipogenesis INTERNATIONAL JOURNAL OF OBESITY 2021
Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
Gain of function of Malate Dehydrogenase 2 (MDH2) and familial hyperglycemia THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2021
All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease ACTA DIABETOLOGICA 2021
A Serum Resistin and Multicytokine Inflammatory Pathway Is Linked with and Helps Predict All-cause Death in Diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2021
Correction to: Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation JOURNAL OF THROMBOSIS AND THROMBOLYSIS 2021
The synergic association of hs-CRP and serum amyloid P component in predicting all-cause mortality in patients with type 2 diabetes DIABETES CARE 2020
PPARA polymorphism influences the cardiovascular benefit of fenofibrate in type 2 diabetes: Findings from accord-lipid DIABETES 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma